Breast Cancer Consultation Service
Women with breast cancer can get a second opinion, seeing a medical oncologist, radiation oncologist and surgeon on the same day. More >>
How Research and Discovery Can Help You
Breast cancer treatment has made great strides in recent years. You have more reason to hope than ever before. The reason is research and discovery. More >>
Breast Health Services
At LVH, our breast cancer detection rates are among the best in the country, thanks in part to state-of-the-art mammography equipment and highly skilled mammography technologists. More >>
Highest Accreditation Available From Commission on Cancer
Lehigh Valley Hospital and Health Network's (LVHHN) Cancer Center has achieved Network Cancer Program accreditation, the highest available from the American College of Surgeons' Commission on Cancer (CoC). More >>
Here is a comprehensive guide to the decision-making process written by a breast cancer survivor and professional writer who’s written several stories for Healthy You magazine.
More >>
Q: I heard the drug, Evista may reduce the risk for breast cancer—is that true? Who can benefit from this medication?
A: U.S. Food and Drug Administration (FDA) approved Evista (the brand name for raloxifene previously used to treat osteoporosis) to help prevent breast cancer in postmenopausal women who are at high-risk for the disease. If you think you’re at increased risk for breast cancer, you should talk with your doctor about whether or not this medication—if any—is right for you.
I wouldn’t have to lose my breast.
“Saving my life was the most important thing to me. But it was very appealing when Dr. Harper said I wouldn’t have to lose my breast.”